Searching the Resource Information Network

Our searching services are busy right now. Please try again later

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility.

Sarah K Denny | Dian Yang | Chen-Hua Chuang | Jennifer J Brady | Jing Shan Lim | Barbara M Grüner | Shin-Heng Chiou | Alicia N Schep | Jessika Baral | Cécile Hamard | Martine Antoine | Marie Wislez | Christina S Kong | Andrew J Connolly | Kwon-Sik Park | Julien Sage | William J Greenleaf | Monte M Winslow
Cell | 2016

Metastases are the main cause of cancer deaths, but the mechanisms underlying metastatic progression remain poorly understood. We isolated pure populations of cancer cells from primary tumors and metastases from a genetically engineered mouse model of human small cell lung cancer (SCLC) to investigate the mechanisms that drive the metastatic spread of this lethal cancer. Genome-wide characterization of chromatin accessibility revealed the opening of large numbers of distal regulatory elements across the genome during metastatic progression. These changes correlate with copy number amplification of the Nfib locus, and differentially accessible sites were highly enriched for Nfib transcription factor binding sites. Nfib is necessary and sufficient to increase chromatin accessibility at a large subset of the intergenic regions. Nfib promotes pro-metastatic neuronal gene expression programs and drives the metastatic ability of SCLC cells. The identification of widespread chromatin changes during SCLC progression reveals an unexpected global reprogramming during metastatic progression.

Pubmed ID: 27374332

Research resources used in this publication

None found

Additional research tools detected in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, United States
    Id: F32 CA189659
  • Agency: NIGMS NIH HHS, United States
    Id: T32 GM008294
  • Agency: NHGRI NIH HHS, United States
    Id: P50 HG007735
  • Agency: NCI NIH HHS, United States
    Id: P30 CA124435
  • Agency: NCI NIH HHS, United States
    Id: R01 CA206540

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.